Lite Strategy (LITS) Interest Income - Net (2024 - 2026)
Lite Strategy (LITS) posted quarterly Interest Income - Net of -$784000.0 for Q1 2026, down 126.59% year-over-year from $2.9 million in Q1 2025, and up 0.88% quarter-over-quarter from -$791000.0 in Q4 2025.
Lite Strategy (LITS) Interest Income - Net (2024 - 2026) Analysis & Trends
Lite Strategy's Interest Income - Net history runs 3 years deep, the most recent figure standing at -$784000.0 for Q1 2026.
- In Q1 2026, Interest Income - Net fell 126.59% year-over-year to -$784000.0; the TTM figure through Mar 2026 stood at -$75.0 million (changed N/A YoY), while the FY2025 annual figure was -$72.7 million, down 603.18% from the prior year.
- Interest Income - Net for Q1 2026 stood at -$784000.0, up from -$791000.0 in the prior quarter.
- The five-year high for Interest Income - Net was $97000.0 in Q3 2025, with the low at -$73.5 million in Q2 2025.
- The 3-year median for Interest Income - Net is -$346000.0 (2025), against an average of -$10.8 million.
- Peak annual rise in Interest Income - Net reached 4950.0% in 2025, while the deepest fall reached 619.09% in 2025.
- Lite Strategy's Interest Income - Net stood at -$110000.0 in 2024, then tumbled by 619.09% to -$791000.0 in 2025, then grew by 0.88% to -$784000.0 in 2026.
- Business Quant data shows LITS's Interest Income - Net at -$784000.0 in Q1 2026, -$791000.0 in Q4 2025, and $97000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - | 54,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -784,000.00 |
| Dec 31, 2025 | -791,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | -73.51 Mn |
| Mar 31, 2025 | -346,000.00 |
| Dec 31, 2024 | -110,000.00 |
| Sep 30, 2024 | -2,000.00 |